APR 14, 2021 8:00 AM PDT

AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free

WRITTEN BY: Tara Fernandez

A patient undergoes chemotherapy and radiation for rectal cancer. How do doctors know whether all the malignant tissue has been destroyed?

Washington University in St. Louis researchers have developed a way to answer this question, using an innovative combination of photoacoustic microscopy, ultrasound, and “deep learning” artificial intelligence neural networks.

This new system, called PAM/US, allows physicians to detect the presence of residual tumors within rectal tissue, even differentiating cancer cells from other tissue abnormalities such as scars.

“Our PAM/US system paired with the deep learning neural network has great potential to better identify patients suitable for nonoperative management and improve patient quality of life,” explained Quing Zhu, lead author of the study. 

“If we can tell after radiation and chemotherapy which patients may have a good response with no residual tumors, the patient may be able to avoid surgery.” This is a huge leap forward in the standard of care for patients with non-metastatic rectal cancers, many of which need to undergo invasive follow-up procedures after cancer therapies.

In the study, Zhu and colleagues describe how the technique would be used in a clinical setting. A patient under anesthesia would have a handheld probe inserted into the rectum. There, a rotating head takes a series of images, 360-degrees around the internal rectal wall. The combination of ultrasound and photoacoustic waves transmitted captures intricate details in the underlying vasculature of the rectum and any tumor growth. The whole procedure takes around 20 minutes to complete.

These images are then fed into an AI-based computational system that draws from a library of over 2,000 images captured from rectal cancer patients to make a diagnosis. The algorithm was found to be highly sensitive, correctly predicting the cancer status of 100 percent of rectal cancer patients.

As the next step, the team plans to expand the validation of their new platform by conducting a larger-scale clinical study in rectal cancer patients who have already undergone chemotherapy and radiation.

 

 

Sources: Radiology, Washington University in St. Louis.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 01, 2021
Clinical & Molecular DX
An Online Tool for Calculating Dementia Risk
JUL 01, 2021
An Online Tool for Calculating Dementia Risk
Picture this: You’ve misplaced your keys again and you no longer feel comfortable in social settings you once enjo ...
JUL 15, 2021
Clinical & Molecular DX
Childhood Lead Exposure Influences Personality in Adulthood
JUL 15, 2021
Childhood Lead Exposure Influences Personality in Adulthood
Exposure to toxic chemicals in childhood could have unlikely effects on personality, and behavioral traits in adulthood, ...
JUL 29, 2021
Drug Discovery & Development
A low-cost drug for the treatment of hepatitis.
JUL 29, 2021
A low-cost drug for the treatment of hepatitis.
      The viral disease, Hepatitis C, is known as a silent killer. Hepatitis C is easily spread thro ...
SEP 06, 2021
Cancer
A New Biomarker to Personalize Breast Cancer Therapy
SEP 06, 2021
A New Biomarker to Personalize Breast Cancer Therapy
The American Cancer Society estimates that over 280,000 women in the United States will be diagnosed with breast cancer ...
SEP 28, 2021
Clinical & Molecular DX
Black College Football Players More at Risk of Heart Conditions
SEP 28, 2021
Black College Football Players More at Risk of Heart Conditions
College football players may have an elevated risk of developing a heart condition where the left side of the heart beco ...
OCT 17, 2021
Microbiology
Harmless Microbes Can be Pressured to Turn Bad
OCT 17, 2021
Harmless Microbes Can be Pressured to Turn Bad
The world is full of microorganisms. Luckily, most pose no threat to us. But some harmless bacteria have the potential t ...
Loading Comments...